Elliptic Laboratories A

Elliptic Laboratories A Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Elliptic Laboratories A (ELABS.OL) as of Nov 1, 2026 is -8.25. In the previous year, Cash Conversion Cycle (CCC) was 301.55 — a change of -102.74% (lower).

Cash Conversion Cycle

-8.25

YoY

-102.74%

Last updated:

Cash Conversion Cycle (CCC) of Elliptic Laboratories A is 2025 -8.25 . Cash Conversion Cycle (CCC) of Elliptic Laboratories A was 2024 301.55 . It decreases by -102.74% lower compared to the previous year.

The Elliptic Laboratories A Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
110.01 NOK
Jan 1, 2019
130.93 NOK
Jan 1, 2020
-4.91 NOK
Jan 1, 2021
172.28 NOK
Jan 1, 2022
274.21 NOK
Jan 1, 2023
306.35 NOK
Jan 1, 2024
301.55 NOK
Jan 1, 2025
-8.25 NOK
The Elliptic Laboratories A Cash Conversion Cycle history
YEARCash Conversion CycleYoY
-8.25-102.74%
301.55-1.57%
306.35+11.72%
274.21+59.17%
172.28-3,609.10%
-4.91-103.75%
130.93+19.01%
110.01+13.56%
96.88—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Elliptic Laboratories A Stock analysis

What does Elliptic Laboratories A do? Elliptic Laboratories ASA develops AI software using ultrasound and sensor-fusion algorithms for 3D gesture and presence sensing in smartphones, laptops, IoT devices, and automotive applications. The company targets enterprise clients in these markets, selling its proprietary AI platform as a solution for intuitive user interactions. Its products are integrated into devices by manufacturers seeking advanced sensing capabilities without additional hardware. The company operates from offices in San Francisco, Oslo, and Shanghai, leveraging its patented technology to serve global technology sectors. Elliptic Laboratories ASA’s revenue comes from licensing its AI platform to device manufacturers across smartphone, laptop, IoT, and automotive segments. The enterprise focuses on delivering sensor-based solutions that enhance user experience through gesture and presence detection. Its core offering is embedded in products where traditional touch interfaces are insufficient, providing a competitive edge for partners in consumer electronics and automotive industries. The company’s business model relies on selling its AI platform through licensing agreements with technology firms. By combining ultrasound with sensor-fusion algorithms, Elliptic Laboratories ASA offers a unique solution for 3D gesture control, which is adopted by manufacturers to improve device functionality. The enterprise targets global markets where touchless interaction is increasingly valued, particularly in high-end smartphones and automotive systems. Elliptic Laboratories A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Elliptic Laboratories A stock

Cash Conversion Cycle (CCC) of Elliptic Laboratories A is -8.25 in 2025.

Cash Conversion Cycle (CCC) of Elliptic Laboratories A changed from 301.55 to -8.25, representing a -102.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Elliptic Laboratories A since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Elliptic Laboratories A with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Elliptic Laboratories A

All Key Metrics — Elliptic Laboratories A